Roche consolidates grip on anti-angiogenesis market.
Nuala
N
Moran
D020533:Angiogenesis Inhibitors / Q000191:economics* / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000639:trends*; D004345:Drug Industry / Q000639:trends*; D006801:Humans; D040541:Marketing / Q000639:trends*; D009389:Neovascularization, Pathologic / Q000188:drug therapy* / Q000191:economics*; D014481:United States
D020533:Angiogenesis Inhibitors